[Scintigraphy with 111In-bleomycin in the diagnosis of recurrences of rectal cancer].
Altogether 76 patients were examined using scintigraphy with 111In-bleomycin. Clinicoroentgenological diagnosis of recurring rectal cancer was confirmed in 62 of them. Fourteen patients were without signs of recurrence. A focus of RP hyperfixation in the small pelvis was revealed on scintigrams in 52 (84%) of 62 patients. In 4 cases the results of examination were considered doubtful, and in 6 cases the results were false positive. Of 14 recurrence-free patients 4 had recurring tumors at early stages prior to clinical manifestations. The authors pointed to the prospects of the employment of 111In-bleomycin for diagnosis of rectal cancer recurrences.
O P
OP
Lenskaia
E L
EL
Ozhiganov
Iu B
IuB
Bogdasarov
D000230:Adenocarcinoma / Q000000981:diagnostic imaging; D000328:Adult; D000368:Aged; D001761:Bleomycin; D005260:Female; D006801:Humans; D007204:Indium; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000000981:diagnostic imaging*; D011877:Radionuclide Imaging; D012004:Rectal Neoplasms / Q000000981:diagnostic imaging*
D007204:Indium; D001761:Bleomycin
Stsintigrafiia s 111In-bleomitsinom v diagnostike retsidivov raka priamoĭ kishki.